PKC Regulates a Farnesyl-Electrostatic Switch on K-Ras that Promotes its Association with Bcl-Xl on Mitochondria and Induces Apoptosis by Bivona, Trever et al.
Molecular Cell 21, 481–493, February 17, 2006 ª2006 Elsevier Inc. DOI 10.1016/j.molcel.2006.01.012PKC Regulates a Farnesyl-Electrostatic Switch
on K-Ras that Promotes its Association with
Bcl-XL on Mitochondria and Induces ApoptosisTrever G. Bivona,2,7 Steven E. Quatela,3,7
Brian O. Bodemann,5 Ian M. Ahearn,2
Michael J. Soskis,2 Adam Mor,1 John Miura,3
Heidi H. Wiener,2 Latasha Wright,2 Shahryar G. Saba,2
Duke Yim,2 Adam Fein,2 Ignacio Pérez de Castro,4,8
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K-Ras associates with the plasma membrane (PM)
through farnesylation that functions in conjunction
with an adjacent polybasic sequence. We show that
phosphorylation by protein kinase C (PKC) of S181
within the polybasic region promotes rapid dissocia-
tion of K-Ras from the PM and association with intra-
cellular membranes, including the outer membrane
of mitochondria where phospho-K-Ras interacts with
Bcl-XL. PKC agonists promote apoptosis of cells trans-
formed with oncogenic K-Ras in a S181-dependent
manner. K-Ras with a phosphomimetic residue at posi-
tion 181 induces apoptosis via a pathway that requires
Bcl-XL. The PKC agonist bryostatin-1 inhibited the
growth in vitro and in vivo of cells transformed with
oncogenic K-Ras in a S181-dependent fashion. These
data demonstrate that the location and function of
K-Ras are regulated directly by PKC and suggest an
approach to therapy of K-Ras-dependent tumors with
agents that stimulate phosphorylation of S181.
Introduction
Although mammalian genomes contain three ras genes,
mutations in K-ras are most frequently associated with
human cancer (Bos, 1989). The differential biology of
Ras isoforms is generated in large part by distinct
membrane-targeting sequences. Membrane associa-
*Correspondence: philim01@med.nyu.edu
7 These authors contributed equally to this work.
8 Present address: Molecular Oncology Program, Spanish National
Cancer Center, Melchor Fernandez Almagro, 3, 28029 Madrid, Spain.tion of all Ras isoforms requires farnesylation, proteoly-
sis, and carboxyl methylation of a C-terminal CAAX
motif. Plasma membrane (PM) targeting of the principal
splice variant of K-Ras also requires a unique polybasic
region adjacent to the CAAX motif (Choy et al., 1999;
Hancock et al., 1990; Jackson et al., 1994). K-Ras thus
falls into a broad class of proteins that are anchored to
the cytoplasmic face of the PM by virtue of posttransla-
tional modification with lipids that act in conjunction
with polybasic stretches of polypeptide. Whereas the
lipid moieties are thought to insert into the phospholipid
bilayer, the polybasic regions are believed to associate
with the anionic head groups of inner leaflet phospho-
lipids (Leventis and Silvius, 1998). Included in this class
of proteins is the myristoylated alanine-rich C kinase
substrate (MARCKS) that associates with the PM via an
N-terminal myristoyl modification and a polybasic re-
gion. Serine residues within the polybasic region aresites
for PKC-mediated phosphorylation (Figure 1A) that neu-
tralize the charge and thereby cause the MARCKS pro-
tein to dissociate from the PM. The mechanism by which
MARCKS is discharged from the PM through phosphor-
ylation has been referred to as a myristoyl-electrostatic
switch (McLaughlin and Aderem, 1995).
Like MARCKS, the polybasic region of K-Ras harbors
three potential phosphorylation sites, and this segment
has previously been shown to be phosphorylated by
PKC (Ballester et al., 1987). We therefore tested the hy-
pothesis that phosphorylation of the C-terminal seg-
ment of K-Ras might regulate its association with the PM
and thereby constitute a farnesyl-electrostatic switch.
We observed that PKC agonists induced a rapid translo-
cation of K-Ras from the PM to intracellular membranes
that included the endoplasmic reticulum (ER) and Golgi
apparatus. Surprisingly, the membranes upon which
phosphorylated K-Ras accumulated also included the
outer mitochondrial membrane where K-Ras associated
with Bcl-XL. Furthermore, phosphorylation and internal-
ization of K-Ras stimulated apoptosis in a Bcl-XL-
dependent fashion. Finally, we show that a PKC agonist
with established anticancer activity limits the growth of
tumors driven by activated K-Ras with a wild-type mem-
brane-targeting region but not oncogenic K-Ras with an
alanine substitution at the principal PKC site. These ob-
servations show that the subcellular localization and
function of K-Ras are modulated by PKC.
Results
PKC Agonists Modulate the Association of K-Ras
with the PM
To determine if PKC activation could affect the localiza-
tion of K-Ras in a fashion analogous to MARCKS, we ex-
pressed K-Ras tagged with green fluorescent protein
(GFP) in a variety of cell types and observed its subcel-
lular localization in living cells before and after stimula-
tion of PKC. We used bryostatin-1, a potent PKC agonist
that, like phorbol esters, binds to the C1 regulatory do-
mains of PKCs and promotes their association with
membranes (Kortmansky and Schwartz, 2003). Before
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482Figure 1. PKC Agonists Stimulate Transloca-
tion of K-Ras from the PM to Internal Mem-
branes
(A) Comparison of the membrane-targeting
sequences present in the MARCKS protein
with K-Ras, H-Ras, and Rac1. Arrowheads in-
dicate putative PKC sites.
(B) Effect of bryostatin-1 (0 and 3 min) on
localization of the indicated constucts in
MDCK cells.
(C) PMA and ionomycin promote internaliza-
tion of GFP-K-Ras12V.
(D) Effect of bryostatin-1 is reversible (10 min
washout).
(E) Bryostatin-1 (1 mM, 5 min) induced translo-
cation of GFP-K-Ras but not GFP-H-Ras ex-
pressed at endogenous levels (IB, right panel)
in MDCK cells. Bars, 10 mm.stimulation, GFP-K-Ras was observed almost exclu-
sively at the PM. Bryostatin-1 induced a rapid (<1 min
onset, 3 min maximal) translocation of the GTPase from
the PM to intracellular membranes (Figure 1B). Phorbol
myristate acetate (PMA) had a similar but much weaker
effect, consistent with its lower potency relative to
bryostatin-1 (Szallasi et al., 1994). However, when PMA
was combined with the calcium ionophore ionomycin,
known to synergize with PMA in stimulating PKCs, the
effects on GFP-K-Ras localization were identical to
those of bryostatin-1 (Figure 1C). GFP extended with the
20 amino acid C terminus of K-Ras behaved in a manner
identical to that of full-length GFP-K-Ras, demonstrat-
ing that all of the information required for both PM tar-
geting and translocation in response to PKC activation
was contained in this region. Neither H-Ras, an isoform
lacking a polybasic region, nor Rac1, a Ras-related
GTPase with a polybasic region devoid of phosphoryla-
tion sites (Figure 1A), was redistributed in response to
PKC agonists (Figure 1B). The localization of K-Ras
extended beyond its CAAX sequence with the hypervari-
able region of H-Ras was also unaffected by PKC ago-
nists (Figure 1B), demonstrating that the H-Ras mem-
brane anchor is dominant when placed in tandem withthe K-Ras polybasic region. The effect of bryostatin-1
on K-Ras localization was reversible (Figure 1D), consis-
tent with a phosphorylation/dephosphorylation cycle,
a conclusion also supported by the observation that
the phosphatase inhibitor, okadaic acid, induced partial
internalization of GFP-K-Ras (data not shown). To rule
out the possibility that the translocation we observed
was a consequence of the overexpression of the GFP-
tagged proteins, we produced MDCK cell lines that
stably express GFP-H-Ras or GFP-K-Ras at levels at
or below those of the endogenous proteins (Figure 1E,
right panel). In these cells, whereas bryostatin-1 induced
internalization of a significant portion of GFP-K-Ras, the
subcellular distribution of H-Ras was unaffected (Fig-
ure 1E). Thus, PKC agonists dynamically regulate the
association of K-Ras with the PM via its C-terminal
segment.
PKC-Mediated Phosphorylation of K-Ras on S181
Promotes K-Ras Internalization
The synergistic effect of ionomycin on PMA-induced
K-Ras translocation raised the possibility that calcium
might play a role beyond the activation of PKCs, since
calmodulin has been shown to associate with (Villalonga
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483Figure 2. PKC Phosphorylates K-Ras on S181 to Promote Internalization
(A) Effect of bryostatin-1 (0 and 3 min) on localization of the indicated constucts in MDCK cells with or without pretreatment with an inhibitor of
calmodulin (W-13) or PKC (Ro-31-8220).
(B) IP of the K-Ras construct indicated from lysates of COS-1 cells metabolically labeled with [32P]orthophosphate and treated 6 bryostatin-1.
(C) Expression of RBD-PKCqcat promotes constitutive internalization of GFP-K-Ras12V but not GFP-K-Ras12VS181A.
(D) Sequence alignment of Ras-related GTPases reveals potential PKC phosphorylation sites.
(E) Crosslinking of the antigen receptor on Jurkat T cells stimulated internalization of GFP-K-Ras (29% 6 1% of cells).
(F) TCR crosslinking of Jurkat cells stimulated [32P] incorporation into endogenous Ras (top panel). The same conditions also stimulated GTP
loading of Ras (middle panel). Bars, 10 mm.et al., 2001) and extract (Fivaz and Meyer, 2005; Sidhu
et al., 2003) K-Ras from membrane fractions in vitro, a
process antagonized by calmodulin inhibitors. Although
bryostatin-1 is not known to mobilize intracellular cal-
cium, suggesting that PKC activation is sufficient for
K-Ras translocation, we nevertheless tested the role of
calmodulin. Pharmacologic inhibition of calmodulin af-
fected neither PMA+Iono nor bryostatin-1-stimulated
(Figure 2A) translocation of K-Ras, suggesting that cal-
modulin does not play a role. In contrast, the PKC inhib-
itor Ro 31-8220 completely blocked K-Ras translocation
(Figure 2A).
Although the effects of PKC activation on K-Ras local-
ization could be indirect, the previous demonstration of
a PKC substrate in the C terminus of K-Ras (Ballester
et al., 1987) suggested that the effect is more likely di-
rect. The C-terminal region of K-Ras harbors three po-tential phosphate acceptors, S171, S181, and T183 (Fig-
ure 1A), although only the serines conform to consensus
phosphorylation sites and previous phosphoamino acid
analysis of K-Ras from cells exposed to PKC agonists
revealed only phosphoserine (Ballester et al., 1987).
Within the C-terminal membrane-anchoring region of
K-Ras, S181 conforms most closely to a consensus PKC
site. Whereas substitution of alanine for serine at posi-
tion 181 completely blocked bryostatin-1-induced trans-
location of GFP-K-Ras, double substitution of S171 and
T183 for alanines did not inhibit K-Ras internalization
(Figure 2A). Substitution of glutamic acid for S181 to
create a phosphomimetic residue resulted in a form of
K-Ras that was constitutively associated with internal
membranes (Figure 2A). These data suggest that K-Ras
is a direct substrate for PKC and that phosphorylation
of S181 mediates translocation.
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formed metabolic labeling with [32P]orthophosphate.
Bryostatin-1 induced phosphorylation of K-Ras that
was markedly diminished with an S181A substitution,
confirming S181 as the major phosphate acceptor (Fig-
ure 2B). However, the low level of 32P incorporation into
the 181A mutant suggests that, although S181 is the pri-
mary site, other minor sites of phosphorylation are likely.
The diminished signal in the S171A mutant suggested
that this residue also serves as a phosphate acceptor.
In contrast, a T183A substitution did not diminish 32P in-
corporation, confirming that phosphorylation of this res-
idue is not involved in regulating K-Ras localization.
Phosphomimetic (glutamic acid) substitution of S171 re-
sulted in some constitutive internalization, although
substitution of S181 was more efficient in this regard,
and a double mutant, GFP-K-Ras12V171E181E, was
indistinguishable from GFP-K-Ras12V181E (data not
shown). Together, our data suggest that, whereas re-
versible phosphorylation of S181 is both necessary
and sufficient to cause K-Ras translocation, phosphory-
lation of S171 may also contribute.
The sufficiency of a single phosphorylation event for
discharge of K-Ras from the PM suggested that the
basal affinity for the PM conferred by the polybasic
region is relatively low. To test this idea, we metaboli-
cally labeled cells with [35S]methionine and tracked by
subcellular fractionation and immunoprecipitation the
localization of GFP-K-Ras stably expressed at a level
equivalent to the endogenous protein (Figure 1E). After
steady-state labeling (17 hr), 23.8% 6 6.8% (mean 6
SEM, n = 3) of GFP-K-Ras was recovered in the high-
speed supernatant. Moreover, when the high-speed
pellet was rehomogenized with unlabeled, isotonic cyto-
sol and then recovered by centrifugation, 39% 6 5%
(mean 6 SEM, n = 4) was recovered in the second
high-speed supernatant. These data suggest that the
binding affinity of K-Ras for membranes is relatively
low such that a partial neutralization of the polybasic re-
gion could be sufficient to significantly affect the overall
membrane affinity.
Next, we reasoned that if bryostatin-1 induces inter-
nalization of K-Ras via recruitment and activation of PKC
at the PM where K-Ras resides, then targeting PKC to
K-Ras in a bryostatin-independent fashion should pro-
mote constitutive internalization. To test this idea, we
expressed the catalytic domain of PKCq fused with the
Ras binding domain (RBD) of Raf-1 and found that, in
cells expressing this construct, GFP-K-RasV12 with a
wild-type C terminus was partially internalized, but
GFP-K-Ras12V181A was not (Figure 2C). This result
confirms that S181 is a PKC site and that its phosphor-
ylation is necessary and sufficient for PKC-induced
translocation of K-Ras to internal membranes.
Our data suggest that PKC regulates the subcellular
localization of K-Ras via a farnesyl-electrostatic switch
analogous to the myristoyl-electrostatic switch that reg-
ulates the localization of MARCKS. Evolutionarily con-
served, consensus phosphorylation sites analogous to
S181 of K-Ras are also found in Ras-related proteins
of both the Ras and Rho families, suggesting that a
prenyl-electrostatic switch may be a general mecha-
nism for a subclass of GTPases (Figure 2D). Indeed,
phosphorylation of these sites in Rap1a (Lerosey et al.,1991; Quilliam et al., 1991) and RhoA (Lang et al., 1996)
has been reported. Moreover, we have observed PKC-
dependent Rnd3 translocation from the PM to internal
membranes that can be mimicked by substituting a neg-
atively charged residue for the Rnd3 serine at the posi-
tion analogous to S181 of K-Ras (A.D.C., unpublished
data).
T Cell Signaling Induces K-Ras Internalization
and Ras Phosphorylation
To verify that the effect observed by direct activation of
PKC with diacylglycerol analogs reflected physiologic
signaling, we studied lymphocytes that are well known
to activate both Ras (Downward et al., 1990) and PKC
(Valge et al., 1988) following engagement of the T cell re-
ceptor (TCR). GFP-K-Ras expressed on the PM of Jurkat
T cells was observed in 29% 6 1% (mean 6 SEM, n = 4)
of cells to rapidly (<5 min) translocate to internal mem-
branes in response to crosslinking of the TCR with
anti-CD3 antibodies (Figure 2E). Both phosphorylation
and GTP loading of endogenous Ras were observed in
Jurkat T cells following stimulation of the TCR (Fig-
ure 2F), demonstrating Ras phosphorylation in response
to physiological signaling.
PKC Induces Translocation of K-Ras from the PM
to ER, Golgi, and Mitochondria
Because farnesylated K-Ras that lacks a polybasic se-
quence in the C-terminal hypervariable region localizes
on the ER and Golgi apparatus (Choy et al., 1999), we
predicted that these would be the intracellular compart-
ments upon which phosphorylated K-Ras accumulates.
Indeed, the clear decoration of the nuclear envelope
with GFP-K-Ras in cells treated with bryostatin-1 identi-
fied the ER as one target compartment (Figures 1B and
2A). This was confirmed by colocalization of YFP-K-Ras
with a CFP-tagged ER marker in bryostatin-1-treated
cells (Figure 3A). Similarly, association with the Golgi ap-
paratus was demonstrated with a CFP-tagged Golgi
marker (Figure 3A). However, the ER and Golgi localiza-
tion did not account for all of the internalized K-Ras. Also
apparent were widely scattered structures that had a ve-
sicular appearance. Unexpectedly, these structures
proved to be mitochondria, as demonstrated by colocal-
ization with MitoTracker Red (Figure 3A). The fluores-
cence pattern around the rim of mitochondria marked
by MitoTracker Red suggested localization on the outer
mitochondrial membrane (Figure 3A, insert). To rule out
the possibility that the mitochondrial localization was
a function of GFP-K-Ras overexpression, we examined
MDCK cell lines that stably express GFP-K-Ras or
GFP-H-Ras at or below endogenous levels. As in the
transiently transfected cells, bryostatin-1 stimulated
rapid association of GFP-K-Ras but not GFP-H-Ras
with mitochondria (Figure 3B).
To determine if endogenous Ras localizes on mito-
chondria in a PKC-dependent fashion, we performed
immunogold EM studies on Jurkat T cells (Figure 3C).
In untreated cells, we observed 6.4 6 0.5 (mean 6
SEM, n = 8) 10 nm gold particles/mm2 of cytoplasm (ex-
cluding PM), of which less than one in three were asso-
ciated with mitochondria. In bryostatin-1-treated cells,
we observed 31.0 6 1.1 gold particles/mm2, of which
49% were associated with mitochondria (p < 0.001)
Phosphorylation of K-Ras Induces Apoptosis
485Figure 3. Phosphorylation of K-Ras Pro-
motes Translocation from PM to ER, Golgi,
and Mitochondria
(A) COS-1 cells expressing YFP-K-Ras12V
and the indicated CFP-tagged compartment
marker or treated with MitoTracker Red
were treated with bryostatin-1 (0 and 6 min).
Inset shows localization on the outer mito-
chondrial membrane. (B) Both bryostatin-1
and PMA + ionomycin stimulated transloca-
tion to mitochondria (arrows) in MDCK cells
expressing GFP-K-Ras at levels below en-
dogenous. (A and B) Bars, 10 mm. (C) Anti-
Ras immunogold electron micrographs of
Jurkat T cells before and after treatment
with bryostatin-1. Arrow, 10 nm gold particle;
N, nucleus; bars, 200 nm.and the rest with ER, Golgi, and nuclear envelope. Of the
mitochondria-associated gold particles in bryostatin-1-
treated cells, 81% were located within 30 nm of the outer
mitochondrial membrane, confirming the fluorescence
results and demonstrating PKC-dependent association
of endogenous Ras with mitochondria. Although the
only antibody that proved useful in the immunogold
EM study was a pan-Ras antibody, the fluorescent stud-
ies strongly suggest that the endogenous Ras observed
on mitochondria was K-Ras.
Phosphorylated K-Ras Promotes Apoptosis
We have shown that Ras proteins can signal from endo-
membranes (Bivona et al., 2003; Chiu et al., 2002).
Accordingly, we sought to determine the signaling
characteristics of K-Ras internalized via its farnesyl-
electrostatic switch. The protean effects of PKC ago-
nists on signaling pathways make interpretation of ex-
periments utilizing these agents difficult. We therefore
sought to specifically determine the effects of phos-
phorylation on S181 on K-Ras signaling by expressing
phosphomimetic K-Ras12V181E and testing its func-tion. However, this approach proved impracticable be-
cause of the surprising observation that expression of
K-Ras12V181E was highly toxic to cells. Ras proteins
have been found to regulate both anti- and proapoptotic
signaling (Cox and Der, 2003). We therefore tested the
possibility that the observed toxicity was a result of
apoptosis. Overexpression of Bcl-2 (Figure 4A) or a
caspase-3/7 inhibitor (data not shown) blocked the tox-
icity of K-Ras12V181E, implicating apoptosis.
To confirm that K-Ras phosphorylated at S181 could
induce apoptosis, we utilized a YFP-tagged caspase-3
sensor that localizes in the cytosol of healthy cells
but enters the nucleus of cells undergoing apoptosis
(Vos et al., 2003a). Exposure of COS-1 cells to UV light
induced translocation of the caspase sensor into the nu-
cleus (Figure 4B). UV exposure of cells expressing GFP-
K-Ras induced apoptosis but did not induce internaliza-
tion of the GTPase (data not shown), demonstrating that
internalization of K-Ras is not a general consequence of
apoptosis. Expression of activated H-Ras61L resulted
in a relatively low apoptotic index similar to that of vec-
tor transfected cells (Figures 4B and 4C). In contrast,
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486Figure 4. K-Ras with a Negative Charge at Position 181 Induces Apoptosis
(A) Expression of K-Ras12V181E in NIH3T3 cells induced cell death that was rescued by coexpression of Bcl-2.
(B and C) Apoptosis (measured as nuclear translocation of a caspase-3 biosensor) of COS-1 cells induced by UV irradiation or expression of the
indicated Ras constructs (n = 4, p < 0.0001 K-Ras12v versus K-Ras12V181E).
(D) Bryostatin-1 stimulated apoptosis in NIH3T3 cells transformed with K-Ras12V but not K-Ras12V181A (n = 9, p < 0.0001 at each time).overexpression of K-Ras12V resulted in a slightly
elevated apoptotic index. Importantly, expression of
K-Ras12V181E induced a high degree of apoptosis (Fig-
ures 4B and 4C). K-Ras12V181A that cannot be phos-
phorylated was less apoptotic than K-Ras12V, sug-
gesting that the low-grade induction of apoptosis by
oncogenic K-Ras in these cells is dependent on S181.
K-Ras17N181E, predicted to be nucleotide free and
therefore incapable of interacting with effectors, was in-
active in the apoptosis assay, demonstrating a GTP de-
pendence for the proapoptotic pathway (Figure 4C).
Coexpression of the Raf-1 RBD with K-Ras12V181E in-
hibited apoptosis (data not shown), confirming that the
effector binding domain of K-Ras12V181E is required
to engage the proapoptotic pathway. K-Ras mutants in
which the C-terminal polylysine sequence is changed
to uncharged polyglutamine localize on the ER and Golgi
but not mitochondria and do not affect cell viability
(Choy et al., 1999; Hancock et al., 1990), suggesting
that it is the mitochondrial localization of K-Ras phos-
phorylated on S181 that is required for apoptosis. The
data suggest that relocalization of K-Ras from the PM
to the mitochondria stimulates apoptosis via a GTP-
dependent interaction on that organelle.
To confirm that K-Ras12V phosphorylated on S181,
like phosphomimetic K-Ras12V181E, is proapoptotic,
we examined the capacity of PKC agonists to induce ap-
optosis of K-Ras-transformed fibroblasts. Both bryosta-tin-1 (Figure 4D) and PMA plus ionomycin (data not
shown) induced apoptosis to a much higher extent in
cells transformed with K-Ras12V than those trans-
formed with K-Ras12V181A. Thus, the sensitization to
PKC-mediated apoptosis afforded by K-Ras transfor-
mation can be attributed to phosphorylation at S181.
K-Ras Interacts with Bcl-XL on Mitochondria
Mounting evidence suggests that Ras can have proa-
poptotic effects in some cellular contexts (Cox and
Der, 2003; Downward, 1998). The most compelling evi-
dence has come from the characterization of a family
of tumor suppressors that promote apoptosis and that
have proven to be Ras effectors. The best characterized
of these is Nore1 (Khokhlatchev et al., 2002). We found
that a dominant-negative form of Nore1 (Khokhlatchev
et al., 2002) had no effect on the ability of K-Ras12V181E
to induce apoptosis, suggesting that phosphorylated
K-Ras induces cell death via a Nore1-independent
pathway.
Apoptosis can be mediated from intrinsic cellular
pathways that originate from the ER and mitochondria
(Breckenridge et al., 2003). Thus, the intracellular locali-
zations of phosphorylated K-Ras include the cyto-
plasmic face of organelles intimately associated with
apoptosis. The Bcl-2 family of proteins regulates apo-
ptosis on these organelles. Apoptosis can be induced
by augmenting the function of a proapoptotic Bcl-2
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antiapoptotic member of the family. Ras has been
reported to interact with Bcl-2 (Rebollo et al., 1999),
suggesting that direct interaction with Bcl-2 or related
proteins could mediate the proapoptotic affects of
phosphorylated K-Ras. We examined by coimmunopre-
cipitation the capacity of K-Ras to associate with vari-
ous Bcl-2 family proteins (Bcl-2, Bcl-XL, Bak, Bax, and
Bid). Although we confirmed association with Bcl-2,
this interaction was insensitive to PKC agonists. In con-
trast, we observed that K-Ras associated with Bcl-XL in
a PKC-dependent fashion (Figures 5A and 5B). More-
over, K-Ras12V181E brought down 4.0- 6 0.8-fold (n =
8, p < 0.005) more Bcl-XL than did K-Ras12V (Figures
5A and 5B). Nucleotide-free K-Ras17N181E was half
as efficient as Ras12V181E in its ability to associate
with Bcl-XL, demonstrating that, in addition to the nega-
tive charge at position 181, the GTP binding state of K-
Ras also contributes to the interaction. To confirm the
interaction of K-Ras with endogenous Bcl-XL, we used
SW480 human colon cancer cells reported to express
a relatively high level of Bcl-XL (Krajewska et al., 1996)
and found that endogenous Bcl-XL interacted with
K-Ras12V and that the interaction was enhanced by
PKC agonists (Figure 5C).
To determine the compartment upon which K-Ras
and Bcl-XL interact, we examined cells expressing
CFP-K-Ras12V and YFP-Bcl-XL before and after stimu-
lation with PKC agonists (Figures 5D and 5E). YFP-Bcl-
XL was observed constitutively on the outer mitochon-
drial membrane, and CFP-K-Ras12V colocalized with
YFP-Bcl-XL on that compartment following treatment
with bryostatin-1 (Figure 5D) or PMA plus ionomycin
(Figure 5E). To determine if this colocalization reflected
an in vivo molecular interaction, we measured fluores-
cence resonance energy transfer (FRET) between the
two fluorophors. By selectively photobleaching the ac-
ceptor (YFP-Bcl-XL) on individual mitochondria and
measuring a release of quenching of the donor (CFP-K-
Ras), we detected FRET with an efficiency of 17% 6 8%,
establishing a PKC-dependent molecular interaction be-
tween K-Ras and Bcl-XL on the surface of mitochondria.
Apoptosis Stimulated by K-Ras12V181E
Requires Bcl-XL
To establish a functional interaction between proapop-
totic K-Ras with a negative charge at position 181 and
Bcl-XL, we studied fibroblasts derived from embryos of
mice null for Bcl-XL or littermate controls. Staurosporine,
etoposide, and calyculin A (data not shown) induced ap-
optosis to a similar degree in Bcl-XL+/+ and Bcl-XL2/2
cells, demonstrating that apoptotic pathways are intact
in both cell types (data not shown). The fact that Bcl-XL-
deficient cells were not hypersensitive to proapoptotic
drugs suggests that other antiapoptotic Bcl-2 family
members compensate for the absence of Bcl-XL. How-
ever, expression levels of Bcl-2 were similar in both
cell types (see Figure S1 in the Supplemental Data avail-
able with this article online). In contrast to the proapop-
totic drugs, K-Ras12V181E induced apoptosis in Bcl-
XL+/+ but not Bcl-XL2/2 cells (Figure 6A). Strikingly,
ectopic expression of Bcl-XL (Figure 6B) restored the
sensitivity of Bcl-XL2/2 cells to apoptosis induced by
coexpressed K-Ras12V181E. Neither Bcl-2 nor Bcl-XLlacking its C-terminal mitochondrial targeting sequence
(Bcl-XLDC) could substitute for full-length Bcl-XL in re-
storing sensitivity to K-Ras12V181E (Figure 6A). Expres-
sion of Bcl-XLDC inhibited K-Ras12V181E-induced apo-
ptosis in COS-1 cells (Figure 6C), confirming a role for
Bcl-XL in another cell type. To confirm that the results
with phosphomimetic K-Ras reflected phosphorylation
at position 181, we stably expressed K-Ras12V181S or
K-Ras12V181A in Bcl-XL+/+ and Bcl-XL2/2 MEFs and
studied the sensitivity of these cell lines to apoptosis
induced by bryostatin-1. Bcl-XL+/+ cells expressing
K-Ras12V181S but not K-Ras12V181A were sensitive.
In contrast, Bcl-XL2/2 MEFs were resistant, regardless
of which K-Ras allele was expressed (Figure 6D). Thus,
Bcl-XL is required for the induction of apoptosis by
K-Ras phosphorylated at position 181.
K-Ras Is Required for Activation-Induced Cell Death
of T Lymphocytes
Lymphocyte development and function require pro-
grammed cell death. Among the ways to induce apopto-
sis of T cells in vitro is to provide a strong stimulus
through the TCR, a process known as activation-induced
cell death (AICD). Because we observed that the same
stimulus led to phosphorylation and internalization of
K-Ras in T lymphocytes (Figures 2E and 2F), we asked
if K-Ras was required for AICD. Jurkat T cells transfected
with a pSUPER plasmid encoding an RNA hairpin effi-
cient in silencing the K-ras gene (Figure S2) were pro-
tected from AICD, whereas the same cells transfected
with a scrambled pSUPER were sensitive (Figure 6E).
Because AICD is thought to be a surrogate for peripheral
tolerance, these data suggest a role for K-Ras in this
physiologically important form of apoptosis.
Bryostatin-1 Inhibits K-Ras-Driven Tumorigenesis
in a S181-Dependent Manner
Our results suggest that, by promoting apoptosis, phos-
phorylation of oncogenic K-Ras on S181 might reverse
cellular transformation and/or tumor progression. To
test this idea, we studied the effect of bryostatin-1 on
K-Ras-dependent transformation in vitro and in vivo.
Bryostatin-1-inhibited K-Ras12V induced colony growth
of fibroblasts in soft agar (Figure 7A). In contrast, soft
agar growth induced by K-Ras12V181A was insensitive
to bryostatin-1. Concordant with these in vitro results,
tumors in nude mice established with fibroblasts trans-
formed with K-Ras12V were sensitive to intraperitoneal
administration of bryostatin-1, but tumors established
with K-Ras12V181A-transformed fibroblasts were resis-
tant (Figure 7B). TUNEL staining of the excised tumors
revealed marked apoptosis of K-Ras12V-driven tumors
treated with bryostatin-1, but tumors driven by K-
Ras12V181A revealed little apoptosis (Figure 7C). Thus,
the K-Ras farnesyl-electrostatic switch inhibits tumor
growth in vivo by promoting programmed cell death.
Discussion
Peripheral membrane proteins have an advantage over
transmembrane proteins in that their subcellular locali-
zation can be rapidly modulated. Many small GTPases
take full advantage of this feature, moving on and off tar-
get membranes as part and parcel of their biological
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(A and B) Coimmunoprecipitation of YFP-Bcl-XL with indicated HA-K-Ras construct in COS-1 cells 6 bryostatin-1 (n = 8, p < 0.005 for K-Ras12V
versus K-Ras12V181E).
(C) Coimmunoprecipitation of K-Ras12V with endogenous Bcl-XL from SW480 human colon carcinoma cells.
(D) Colocalization of YFP-K-Ras12V (green) and CFP-Bcl-XL (red) on mitochondria of COS-1 cells treated with bryostatin-1 (5 min). The FRET
efficiency between YFP-K-Ras12V and CFP-Bcl-XL on treated mitochondria (inset) was 17% 6 8%.
(E) Colocalization of YFP-K-Ras12V (blue) and CFP-Bcl-XL (green) on mitochondria (red) of HeLa and COS-1 cells treated with PMA plus iono-
mycin (5 min). Bars, 10 mm.tasks. For example, many Rho and Rab family proteins
cycle between membranes and their cytosolic chaper-
ones as part of their activation process (Michaelson
et al., 2001; Seabra and Wasmeier, 2004). In contrast,mature Ras proteins were thought until recently to asso-
ciate irreversibly with the PM. This view is somewhat
counterintuitive, since Ras proteins, unlike most Rho
and Rab proteins, are modified with a single 15 carbon
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489Figure 6. Apoptosis Induced by Phosphory-
lated K-Ras Is Dependent on Expression of
Bcl-XL, and AICD of T Cells Requires K-Ras
(A) Apoptosis measured by caspase-3 bio-
sensor in Bcl-XL+/+ or Bcl-XL2/2 MEFs ex-
pressing the indicated K-Ras construct with
or without coexpression of Bcl-XL, Bcl-
XLDC, or Bcl-2 (n = 12, p < 0.0001, Bcl-XL+/+
versus Bcl-XL2/2 expressing K-Ras12V181E).
(B) Equivalent expression of Bcl-XL, Bcl-
XLDC, and Bcl-2.
(C) Bcl-XLDC inhibited K-Ras12V181E-in-
duced apoptosis of COS-1 cells (n = 4, p <
0.01).
(D) Apoptosis following bryostatin-1 treat-
ment of Bcl-XL+/+ or Bcl-XL2/2 MEFs express-
ing the indicated K-Ras construct (n = 4, p <
0.001, 360 min, K-Ras12V181E versus K-
Ras12V181A in Bcl-XL+/+ and K-Ras12V181E
in Bcl-XL+/+ versus Bcl-XL2/2).
(E) AICD (6 anti-CD3/28) of Jurkat T cells
measured by caspase-3 biosensor (inset)
with or without silencing of K-Ras by siRNA
(n = 5, p < 0.001).farnesyl lipid rather than one or two 20 carbon geranyl-
geranyl lipids and thereby have less intrinsic affinity for
membranes. Indeed, we have recently found that,
whereas reversible carboxyl methylation of the C-termi-
nal prenylcysteine that adds to its hydrophobicity is
required for membrane association of Ras proteins, it
is not required for Rho proteins (Michaelson et al.,
2005), suggesting that the shorter prenyl modification
evolved to afford relatively weak and reversible affinity
for membranes.
It is now clear that the palmitoylated forms of Ras sig-
nal from endomembrane as well as the PM (Bivona et al.,
2003; Chiu et al., 2002) and that a palmitoylation/depal-
mitoylation cycle (Magee et al., 1987) regulates bidirec-
tional trafficking of these Ras isoforms between the
Golgi and the PM (Goodwin et al., 2005; Rocks et al.,
2005). Moreover, the retrograde trafficking from the
PM to the Golgi of depalmitoylated Ras involves a cyto-
solic intermediate (Rocks et al., 2005), demonstrating
conclusively that the farnesyl membrane anchor is rela-
tively weak. Recently, K-Ras has been shown to translo-
cate from the PM to the Golgi in hippocampal neurons
stimulated with glutamate, and evidence was presented
that the mechanism for K-Ras dissociation from the PM
in this system was dependent on Ca2+/calmodulin (Fivaz
and Meyer, 2005). However, this mechanism is unlikelyto account for the K-Ras translocation that we have
observed. First of all, phosphorylation of even a single
serine in the polybasic region MARCKS dramatically
decreases Ca2+/calmodulin binding by 200-fold (McIlroy
et al., 1991), yet our data show conclusively that
phosphorylation of S181 is required for translocation in
response to PKC activation. Second, whereas PKC in-
hibitors blocked K-Ras translocation, Ca2+/calmodulin
inhibitors did not. We therefore favor a model that we
have called the farnesyl-electrostatic switch, whereby
the membrane affinity of K-Ras is modulated by phos-
phorylation within its polybasic region in a manner
analogous to the myristoyl-electrostatic switch of the
MARCKS protein. Phosphorylation at S181 acts to par-
tially neutralize the charge and destabilize the electro-
static interaction with negatively charged phospholipid
headgroups on the inner leaflet of the PM.
The sufficiency of a single phosphorylation event to
trigger the K-Ras farnesyl-electrostatic switch suggests
that the affinity of K-Ras for membranes is relatively
weak, a conclusion supported by several in vitro obser-
vations. Seventy percent of GFP fused to a K-Ras tail
could be extracted from cellular membranes with an-
ionic phospholipid vesicles (Roy et al., 2000). Similarly,
70% of K-Ras was extracted from membrane vesicles
with 0.25 M salt (Hancock et al., 1990). Substitution of
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490Figure 7. Phosphorylation Inhibits K-Ras12V-Mediated Transformation In Vitro and In Vivo
(A and B) S181 was required for inhibition by bryostatin-1 of (A) K-Ras12V-dependent growth in soft agar and (B) K-Ras12V-dependent tumor
growth in nude mice. Only the curves representing K-Ras12V-dependent tumors 6 bryostatin-1 were statistically different (p < 0.05, ANOVA).
(C) TUNEL stain of tumors excised from animals treated as indicated with tumors driven by either K-Ras12V or K-Ras12V181A.glutamine for two of the six contiguous lysines, the elec-
trostatic equivalent of adding a phosphate group, re-
sulted in recovery of 34% of K-Ras in the soluble fraction
(Hancock et al., 1990). Our data reveal that 40% of total
K-Ras can be extracted from total membrane fractions
with isotonic cytosol. These data suggest that even a
partial neutralization of the overall charge of the K-Ras
polybasic region may be sufficient to significantly affect
membrane affinity.
The Golgi and ER localization of phosphorylated K-
Ras was not surprising, since K-Ras mutants with gluta-
mines substituted for the lysines of the polybasic region
were previously found on these compartments (Choy
et al., 1999). Not so the mitochondrial localization that
has not previously been observed in intact cells ex-
pressing GFP-tagged Ras proteins. The basis for the af-
finity of phosphorylated K-Ras for the outer mitochon-
drial membrane may reflect the phospholipid content
of this compartment or the presence of a specific accep-
tor. Alternatively, or in addition, the interaction that we
demonstrated between phospho-K-Ras and Bcl-XL, a
constitutive component of the outer mitochondrial
membrane, may explain the affinity.
Although usually thought of as promoting cell growth
and survival, the proapoptotic effects of Ras in somecellular contexts are well described (Cox and Der,
2003). Furthermore, isoform differences in the proapop-
totic effects of Ras have been observed. For example,
whereas K-Ras-transformed fibroblasts are sensitized
to g irradiation-induced apoptosis, H-Ras-transformed
cells are protected (Choi et al., 2004). Our data demon-
strate that activated K-Ras sensitizes cells to the proa-
poptotic effects of PKC agonists in an S181-dependent
fashion. Combined with our demonstration that S181 is
the principal PKC site on K-Ras, this offers compelling
evidence for a proapoptotic function of K-Ras phos-
phorylated at S181. Our demonstration that activated
K-Ras with a phosphomimetic substitution at position
181 potently induces apoptosis supports this conclu-
sion. The finding that K-Ras phosphorylated on S181
is released from the PM and targets to the ER and mito-
chondria, organelles intimately involved in regulating
apoptosis (Kuwana and Newmeyer, 2003; Scorrano
et al., 2003), suggests a cell biological basis for the
switch from a prosurvival to a proapoptotic molecule.
Since K-Ras with a polyglutamine substitution for the
polylysine sequence localizes to the ER but does not
affect cell viability, we deduce that the mitochondrial-
localized phospho-K-Ras is responsible for proapop-
totic signaling.
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sis, either by abruptly disengaging from prosurvival sig-
naling down the PI3 kinase pathway or by engaging
proapoptotic pathways (Cox and Der, 2003; Downward,
1998). The potent proapoptotic effect of K-Ras12V181E
that we observed in cells with intact endogenous Ras
signaling strongly suggests the latter. The best-studied
proapoptotic Ras effectors are the RASSF family of
tumor suppressors (Eckfeld et al., 2004). We found that
a dominant-negative form of Nore1, the best-character-
ized member of this family (Khokhlatchev et al., 2002),
was ineffective at blocking K-Ras12V181E-stimulated
apoptosis. Because Ras proteins have been reported
to interact with Bcl-2 family proteins (Rebollo et al.,
1999), we explored the possibility that this type of inter-
action might mediate apoptosis and found that apopto-
sis induced by K-Ras phosphorylated at S181 requires
Bcl-XL.
Programmed cell death can be enhanced by positively
regulating a proapoptotic Bcl-2 family (e.g., Bak, Bax, or
Bid) member or inhibiting the action of an antiapoptotic
family member (e.g., Bcl-2 and Bcl-XL). Another intrigu-
ing possibility is the conversion of a generally antiapop-
totic Bcl-2 family protein into a proapoptotic molecule.
This has been shown to occur for Bcl-2 when it interacts
with the nuclear orphan receptor Nur77/TR3 (Lin et al.,
2004). In support of the potential for conversion of Bcl-
2 is the observation that overexpression of this protein
can stimulate programmed cell death (Uhlmann et al.,
1998). Interestingly, whereas Bcl-2 targeted to the mito-
chondria can induce apoptosis, ER-targeted Bcl-2 can-
not (Wang et al., 2001), establishing the mitochondria as
the site of action of converted Bcl-2. The relatively weak
interaction that we observed between phosphorylated
K-Ras and Bcl-XL makes less plausible a model in which
phospho-K-Ras promotes apoptosis by stoichiometri-
cally sequestering Bcl-XL. On the other hand, a model
in which phospho-K-Ras on the outer mitochondrial
membrane converts Bcl-XL to a proapoptotic protein is
consistent with all of our data.
Removal of K-Ras from the PM may be a mechanism
to acutely downregulate signaling for survival and
growth. By promoting apoptosis, the K-Ras farnesyl-
electrostatic switch can further act to limit the effects
of K-Ras inappropriately activated by mutation or con-
stitutive activation of upstream pathways. In support
of this idea, we have found that a K-Ras allele devoid
of phosphorylation sites in its C-terminal hypervariable
region is hypertransforming (M.R.P. and A.D.C., unpub-
lished data). Because all screening for K-ras mutations
in human cancer has been limited to exons 1 and 2, it re-
mains to be determined if codon 181 within exon 4B is
a site for naturally occurring mutations in human cancer.
In support of a physiologic role of K-Ras phosphoryla-
tion in promoting apoptosis, we have shown that AICD
in T lymphocytes depends on K-Ras expression and
that the conditions under which AICD is induced in these
cells stimulate phosphorylation and translocation of en-
dogenous Ras.
The proapoptotic pathway that we have characterized
in this study is extremely significant, since it could be
exploited to develop anticancer drugs that are specific
for tumors driven by oncogenic K-Ras. We have tested
this idea by assessing the anti-neoplastic effects ofbryostatin-1, a PKC agonist already used in clinical trials
(Kortmansky and Schwartz, 2003), in limiting the growth
of K-Ras-dependent tumors. We found that, whereas
bryostatin-1 was effective against tumors in nude mice
derived from cells transformed with conventional onco-
genic K-Ras12V, it lost its efficacy in tumors driven by
K-Ras12V181A. This demonstrates that the antitumor
action of bryostatin-1 was dependent on S181, the res-
idue we found to be phosphorylated in response to the
drug. This result suggests that agents that promote
phosphorylation of K-Ras on S181 have the potential
to be K-Ras-specific anticancer agents.
Experimental Procedures
Cell Culture, Transfection, and Metabolic Labeling
Cells were cultured and transfected (Bivona et al., 2003) and meta-
bolically labeled with [32P]orthophosphate (Ballester et al., 1987)
as described. Details are also provided in Supplemental Data.
Cell Stimulation and Imaging
Cells were stimulated while under continuous observation by adding
100 nM bryostatin-1 (Biomol), 100 nM PMA with or without 500 ng/ml
ionomycin, or 5 ng/ml anti-CD3 to 35 mm MatTek plates maintained
at 37ºC using a PDMI-2 microincubator (Harvard Apparatus). Treat-
ment of cells with 100 nM Ro 31-8220 (Biomol) or 15 mg/ml W-13
hydrochloride (EMD Biosciences) was initiated 10 min prior to stim-
ulations. Where indicated, 25 pM MitoTracker Red CMXRos (Molec-
ular Probes) was added 10 min prior to stimulation. Living cells were
imaged with a Zeiss 510 inverted laser scanning confocal micro-
scope. A minimum of five 0.45 mM Z slices were acquired for each
cell at each time point, and representative images were chosen to
display both PM and endomembranes. Unless otherwise stated,
all images shown are representative of >90% of cells examined
(10–100 cells examined per plate, n R 6). FRET on mitochondria be-
tween CFP-K-Ras and YFP-Bcl-XL was detected by bleaching the
acceptor (YFP-Bcl-XL) on individual mitochondria and measuring
the increase in CFP emission intensity as quenching was released.
FRET efficiency was calculated as [ICFP(postbleach) 2 ICFP(prebleach)]/
ICFP(postbleach). TIFF imageswereprocessedwith AdobePhotoshop7.0.
Immunogold Electron Microscopy
Jurkat cells (in suspension) were treated with 100 nM bryostatin-1 or
vehicle (DMSO) for 30 min at 37ºC and then fixed with 2% formalde-
hyde and 0.2% glutaraldehyde in 0.1 M sodium phosphate buffer (pH
7.4). After washing in buffer, the cells were pelleted by centrifuga-
tion, embedded in 10% gelatin, cooled in ice, and cut into 1 mm3
blocks. The blocks were infused with 2.3 M sucrose at 4ºC for at
least 2 hr, frozen in liquid nitrogen, and stored until cryoultramicrot-
omy. Sections 100 nm thick were cut at 2120ºC using an Ultracut
T/FCS (Leica) equipped with an antistatic device (Diatome) and a di-
amond knife (Drukker). Ultrathin sections were picked up in a mix of
1.8% methylcellulose and 2.3 M sucrose (1:1) (Liou et al., 1996). Cry-
osections were collected on formvar-coated copper grids and incu-
bated with Ras10 monoclonal antibody (Upstate) followed by rabbit
anti-mouse antibodies and then protein A gold (Slot and Geuze,
1985). After labeling, the sections were treated with 1% glutaralde-
hyde, counterstained with uranyl acetate, and embedded in methyl
cellulose-uranyl acetate (Slot et al., 1991). Images were acquired
with a JEOL electron microscope JEM-1200 EX II at 80 kV.
Caspase-3 Activation
The assay was performed as described (Vos et al., 2003b).
Coimmunoprecipitation
COS-1 cells were cotransfected with GFP-tagged Bcl-2, Bcl-XL,
Bak, Bax, or Bid and either HA-tagged K-Ras12V, 12V181E, or
17N181E constructs. Twenty-four hours later, the cells were lysed
and Ras was immunoprecipitated with Y13-259 rat monoclonal
pan-Ras antibody. Immunoprecipitates were analyzed in duplicate
by immunoblot with either Ras10 anti-Ras monoclonal antibody or
anti-GFP polyclonal antiserum. To analyze endogenous Bcl-XL,
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treated 24 hr later with vehicle, bryostatin-1, or PMA/ionomycin.
The cells were then lysed in RIPA buffer containing protease inhibi-
tors (Roche), microcystin, and NaF. Bcl-XL was immunoprecipitated
with anti-Bcl-XL monoclonal antibody 7B2.5 and then collected on
protein G beads. Immunoprecipitates were analyzed in duplicate
by immunoblot with either anti-Bcl-XL monoclonal antibody 13.6 or
Ras10 anti-Ras monoclonal antibody. Immunoprecipitated proteins
were detected by [125I]protein A and quantified by PhosphorImager.
Activation-Induced Cell Death
Jurkat T cells (2 3 106) were transfected using DMRIE-C with 1.5 mg
of YFP-caspase-3 sensor DNA and 5 mg of either pSuperRetro-Kras
(K-Ras nt 25–43, 50-GTTGGAGCTGGTGGCGTAG-30) or pSuperRetro-
Scrambled. Eighteen hours after transfection, the cells were stimu-
lated with soluble anti-CD3 (1 mg/ml) and anti-CD28 (1 mg/ml) for an
additional 54 hr. Transfected cells were imaged alive by epifluores-
cence microscopy on MatTek plates, and apoptosis was scored as
nuclear fluorescence.
Soft Agar Assays
NIH 3T3 cells stably transfected with pCGN-hyg or the same vector
encoding K-Ras12V or K-Ras12V181A were plated as single cell
suspensions (2 3 104 cells per 35 mm well) in 0.4% agar over a bot-
tom layer of 0.6% agar, both containing DMSO vehicle or various
concentrations of bryostatin-1. After 2 weeks, the percentage of
plated cells that formed colonies (>5 cell diameters across) was
determined.
Tumor Growth Assays
NIH 3T3 cells stably transfected as per the soft agar assays were in-
jected (5 3 105 cells) subcutaneously into the flanks of 4- to 6-week-
old athymic nude BALB/c mice. After formation of palpable tumors,
mice were treated daily for 3 days with intraperitoneal DMSO or
bryostatin-1 (25 mg/kg). Tumor volume was measured daily, and dif-
ferences in growth rates were evaluated for statistical significance
by ANOVA.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and two figures and can be found with this article online at http://
www.molecule.org/cgi/content/full/21/4/481/DC1/.
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